Acoziborole: Investigational Single-Dose Oral Treatment Raises Hope for Elimination of Sleeping Sickness in Africa
Acoziborole: Investigational single-dose oral treatment raises hope for elimination of sleeping sickness in Africa Positive Phase II/III study results support acoziborole’s potential in treatment for deadly... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 30, 2022 Category: Pharmaceuticals Source Type: clinical trials

Prospective Evaluation of the Specificity of Serological Tests for Human African Trypanosomiasis
Conditions:   Human African Trypanosomiasis;   Sleeping Sickness;   Trypanosoma Brucei Gambiense; Infection;   West African Sleeping Sickness Interventions:   Diagnostic Test: Serological field test for HAT;   Diagnostic Test: malaria rapid test;   Diagnostic Test: Immunologic laboratory tests;   Diagnostic Test: Molecular laboratory tests Sponsors:   Institut de Recherche pour le Developpement;   Foundation for Innovative New Diagnostics;   Programme National de lutte contre la THA, Guinée;   Université Jean Lorougnon Guédé, Daloa;   Institut Pasteur, GuinÃ...
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials

Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP3 Post Elimination Monitoring
Conditions:   Human African Trypanosomiasis;   Sleeping Sickness;   Trypanosoma Brucei Gambiense; Infection;   West African Sleeping Sickness;   African Trypanosomiases;   Trypanosomiasis; African, Due to Trypanosoma Brucei Gambiense, Gambiense Intervention:   Diagnostic Test: Rapid diagnostic test (RDT); Serological and molecular tests on DBS Sponsors:   Institut de Recherche pour le Developpement;   Ministry of Public Health, Democratic Republic of the Congo;   Institut National de Sante Publique, Côte d'Ivoire;   CIRDES, Burkina Faso;   Institut National de Recherche Biomédicale. Kinshasa,...
Source: ClinicalTrials.gov - September 23, 2019 Category: Research Source Type: clinical trials